A one-two punch: Two-drug blood pressure therapy lowers cardiovascular risk

[Guest guest]

Interesting University of Michigan BP study headed by Jamerson, M.D.

http://www2.med.umich.edu/prmc/media/newsroom/details.cfm?ID=118

Val

[Guest guest]

My concern with this study was that it did not start with HCTZ first

as was done in SHEP, MRFIT, ALLHAT, and HDFP and VA studies. I see

no reason to use 2 drugs when 1 will do the job.

Also if you read it the average fall in BP is the same as seen in HTN

with the low sodium DASH.

On Aug 22, 2008, at 10:37 PM, Valarie wrote:

> Interesting University of Michigan BP study headed by

> Jamerson, M.D.

>

> http://www2.med.umich.edu/prmc/media/newsroom/details.cfm?ID=118

>

> Val

>

>

[Guest guest]

Ahh, the voice of reason. The study was funded by Novartis. I guess that

should be a consideration. Thanks for straightening us out once again.

Val

From: hyperaldosteronism

[mailto:hyperaldosteronism ] On Behalf Of Clarence Grim

My concern with this study was that it did not start with HCTZ first

as was done in SHEP, MRFIT, ALLHAT, and HDFP and VA studies. I see

no reason to use 2 drugs when 1 will do the job.

Also if you read it the average fall in BP is the same as seen in HTN

with the low sodium DASH.

On Aug 22, 2008, at 10:37 PM, Valarie wrote:

> http://www2.med.umich.edu/prmc/media/newsroom/details.cfm?ID=118